Health
Chronicle Pharmabiz
Home-grown CAR-T cell therapies gaining ground
INDIAN biotech and pharmaceutical companies are actively working on innovative solutions to make CART cell therapy both accessible and cost-effective.
4 min |
November 27, 2025
Chronicle Pharmabiz
NPPA extends price fixation on orthopaedic implants for 1 year
IN a move that will disappoint the industry, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation it imposed on orthopaedic knee implants for knee replacement system for one more year.
1 min |
November 27, 2025
Chronicle Pharmabiz
FICCI envisages it's Smart AAMs to boost healthcare
In line with the Central Government's vision of comprehensive primary healthcare, FICCI Swasth Bharat Task Force has undertaken a transformative initiative titled 'Smart Ayushman Arogya Mandirs-AAMs' (earlier called Health & Wellness Centres) aimed at strengthening the primary healthcare delivery system across India.
1 min |
November 27, 2025
Chronicle Pharmabiz
DoP asked to bring policy for affordable drug pricing
THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DoP) to take steps to come out with a pharmaceutical policy with thrust to provide both scheduled and nonscheduled formulations at affordable prices.
1 min |
November 27, 2025
Chronicle Pharmabiz
Ramaiah emphasises need for bone health and osteoporosis diagnosis
RAMAIAH Memorial Hospital (RMH), a multi-superspecialty quaternary care hospitals emphasises on bone health and osteoporosis diagnosis. It calls for timely screening and diagnosis through the new and advanced DXA scanner with superior and accurate test results.
2 min |
November 27, 2025
Chronicle Pharmabiz
Nathealth calls for action in 2026-27 Union Budget
NATHEALTH has submitted its budget 2026-27 recommendations to the Union government, outlining a roadmap to strengthen healthcare delivery, foster innovation, and expand insurance and preventive coverage.
1 min |
November 27, 2025
Chronicle Pharmabiz
Hotspots & growth opportunities in biomanufacturing
THE Indian bioeconomy has grown from US$ 10 billion in 2014 to US$ 165.7 billion in 2024, and is likely reach US$ 300 billion by 2030.
3 min |
November 27, 2025
Chronicle Pharmabiz
Omega Hospitals acquires Cytecare Hospitals
Morgan Stanley PE backed Hyderabad-based Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru.
2 min |
November 27, 2025
Chronicle Pharmabiz
Devices sector hails withdrawal of QCOs
THE medical devices manufacturers industry in the country has welcomed the Central government's decision to withdraw multiple Quality Control Orders (QCOs) imposed on essential raw materials across various industries, including the medical devices sector.
1 min |
November 27, 2025
Chronicle Pharmabiz
'There is urgent need for tech-focused regulatory approach for med devices'
THE Indian healthcare industry has evolved at a breakneck pace, but its regulatory framework has struggled to keep up to its speed of development.
2 min |
November 27, 2025
Chronicle Pharmabiz
AI profoundly transforming pharma & healthcare sectors
THE rapidly advancing AI models are profoundly transforming the healthcare and pharmaceutical industry, driving innovation across all operations.
10 min |
November 27, 2025
Chronicle Pharmabiz
K'taka works towards Zero Human Deaths due to Dog Mediated Rabies by 2030
THE Karnataka government has put in place aggressive measures to work towards Zero Human Deaths due to Dog Mediated Rabies by 2030, an initiative driven by the World Health Organisation which comes under the umbrella of One Health.
1 min |
November 27, 2025
Chronicle Pharmabiz
Maharashtra FDA enhances regulatory oversight
As Maharashtra continues to evolve as a pharmaceutical hub, the Maharashtra Food and Drug Administration (FDA) remains steadfast in its mission to ensure quality, efficacy, and safety of drugs through enhanced vigilance, infrastructure upgrades, and technological innovation, even in the face of manpower constraints.
4 min |
November 27, 2025
Chronicle Pharmabiz
'Need to strengthen regulatory between UK, India'
THE Association of Indian Medical Device Industry (AiMeD) is the umbrella association representing over 1,200 manufacturers of medical devices across India, has said that the ongoing Comprehensive Economic and Trade Agreement (CETA) and a potential Mutual Recognition Agreement anchored on Indian Certification for Medical Devices (ICMED) certification, among others can strengthen regulatory alignment between the medial devices industry of UK and India.
1 min |
November 27, 2025
Chronicle Pharmabiz
Recognising IP in Ethiopia will make easy availability of drugs: Officials
RECOGNISING Indian Pharmacopoeial (IP) standards in Ethiopia will ensure drugs to be supplied at short notices, making the availability of essential drugs easier, according to officials associated with a high-level Ethiopian delegation which has arrived in India recently.
1 min |
November 27, 2025
Chronicle Pharmabiz
Limitations of LOCF method for handling missing data
MISSING data are an inevitable aspect of clinical trials and present a significant challenge for researchers.
6 min |
November 27, 2025
Chronicle Pharmabiz
Theranostics, a groundbreaking approach in oncology
In the past several years there were significant advancements in the diagnostic and therapeutic potentials of nuclear medicine.
6 min |
November 27, 2025
Chronicle Pharmabiz
Indian pharma ushering in new era of affordable medicines
INDIA has emerged as a hub of cost -effective medicines for not only developing countries, but also for highly regulated markets Like USA, Canada and Europe.
5 min |
November 27, 2025
Chronicle Pharmabiz
Suitable CAPEX and OPEX models from CONDOT
In the pharmaceutical industry, accuracy, traceability, and compliance are nonnegotiable.
2 min |
November 27, 2025
Chronicle Pharmabiz
"Revolutionizing Heart Care & Empowering Patients:" Sirolimus-Driven Balloon Innovation Emerges as a More Effective Alternative to Stents in Larger Arteries
Sirolimus-Driven Balloon Innovation Emerges as a More Effective Alternative to Stents in Larger Arteries
2 min |
November 27, 2025
Chronicle Pharmabiz
Samrudh Pharmacare delivers quality goods on time
SAMRUDH Pharmacare Private Ltd is one of the leading manufacturing companies in India specialized in external formulation.
1 min |
November 27, 2025
Chronicle Pharmabiz
Advancing ADHD Care through integrative approach
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental diseases in children and adolescents.
4 min |
November 27, 2025
Chronicle Pharmabiz
DoP steps on gas to expedite bulk drugs park infra
In an effort to help reduce the manufacturing cost of bulk drugs and also enhance the competitiveness of the domestic industry, the Department of Pharmaceuticals (DoP) is expediting the process of developing infrastructure for bulk drug parks with the State governments.
6 min |
November 27, 2025
Chronicle Pharmabiz
Govt seeks industry inputs on market access challenges
The Union Commerce Ministry has sought industry inputs on market access challenges for Indian pharmaceuticals in Russia.
1 min |
November 27, 2025
Chronicle Pharmabiz
Ayurveda gaining significant traction in global markets
DRIVEN by the growing demand for natural and holistic wellness products, Ayurveda is gaining significant traction in international markets.
5 min |
November 27, 2025
Chronicle Pharmabiz
Pharma exports decline 5.15 per cent in October
FOR the first time in the current fiscal, exports of drugs and pharmaceuticals from the country have reported a decline of 5.15 per cent during the month of October, 2025, on a Year-over-Year (YoY) basis.
1 min |
November 27, 2025
Chronicle Pharmabiz
iCHA Model addresses barriers to make diabetes management reach last mile
THE iCHA Model is addressing barriers like lack of regular screening, limited access to specialists, and limited lifestyle awareness to make diabetes management reach last mile.
2 min |
November 27, 2025
Chronicle Pharmabiz
AI, biotech & telemedicine shaping future of healthcare
The healthcare sector in India is undergoing a dramatic transformation due to the increasing use of Artificial Intelligence (AI), remote medical services, and advancements in biotechnology.
6 min |
November 27, 2025
Chronicle Pharmabiz
Indian API industry stands at threshold of transformation
THE active pharmaceutical ingredients (API) industry in India stands at the threshold of a transformation with backward integration and reduced import dependence, growth in high-value, niche APIs, improved regulatory compliance and quality focus, sustainability & Green API manufacturing, digital & virtual API supply chain models, opine experts.
7 min |
November 27, 2025
Chronicle Pharmabiz
KSRPO alerts Govt about rising sales of Sch-H, H-1 & X drugs by fake Ayush docs
THE Karnataka State Registered Pharmacist Organization (KSRPO) has alerted the state government about the increasing sales of Schedule-H, Schedule-H-1 and Schedule-X medicines by fake Ayush doctors.
2 min |